Entity > Corporation > US > New York City New York > Exelixis

About Exelixis

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Exelixis

Company Attribute Value
Name Exelixis
Url exelixis
Google google
Wikidata wikidata



New York City, US
18 Jul 2024

New York City, US
18 Jul 2024


Page: 1 Desktop | Laptop Devices

Shaping the Future of Oncology for Patients l Exelixis
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the ...
https://en.wikipedia.org › wiki › Exelixis
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. ...
At Exelixis, we offer our employees and their families a wide range of benefits, including virtual wellness resources and educational support. Learn more at bit ...
https://finance.yahoo.com › quote › EXEL
Exelixis, Inc. (EXEL) Stock Price, News, Quote & History
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the ...
https://ipira.berkeley.edu › exelixis-inc
Exelixis, Inc. | Intellectual Property & Industry Research Alliances
Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and ...
https://www.cnbc.com › quotes › EXEL
EXEL: Exelixis Inc - Stock Price, Quote and News
Exelixis, Inc. is an oncology company. The Company is engaged in developing medicines and combination regimens at the forefront of cancer care.
Exelixis (@ExelixisInc) / X
We take pride in our ongoing efforts to foster a diverse and inclusive scientific community where everyone can explore a career in STEM.
Related Searches
Related Searches
Exelixis layoffs
Exelixis pipeline
Exelixis meaning
Knowledge Panel
Knowledge Panel

Exelixis (Biotech company)


Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

  • Stock price : EXEL (NASDAQ) $22.51 -0.25 (-1.10%)Jul 17, 4:00 PM EDT - Disclaimer
  • Headquarters : Alameda, CA
  • CEO : Michael M. Morrissey (Jul 2010–)
  • Subsidiaries : Exelixis Patent Company LLC, Exelixis U.S., LLC, MORE
  • Founders : Stelios Papadopoulos, Corey S. Goodman
  • Revenue : 1.435 billion USD (2021)
  • Founded : November 15, 1994, Cambridge, MA
  • President : Michael M. Morrissey

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 89677